Millions could benefit from genetic screening before prescribing, new research finds
Research led by the University of East Anglia in collaboration Boots UK and Leiden University
Read More
Tag: Pharmacogenomic testing
- FDA approves new high dose Spinraza regimen for SMA
- Viridian reports positive results from elegrobart phase 3 trial
- Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call
- Kygevvi approved in Europe as first treatment for TK2d
- Tozorakimab shows significant benefit in two major COPD trials
